Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NHS-like protein 2 (NHSL2) is a cytoplasmic protein predicted to have calcium ion binding activity and to be involved in cell differentiation[1][3][5][9][11]. The gene encoding NHSL2 (HGNC: 33737; NCBI Gene: 340527) is a paralog of the NHS gene. NHSL2 spans 1,189 amino acids and contains a WAVE homology domain (WHD), suggesting a possible role in regulating cytoskeletal dynamics[3]. Expression data indicate cytoplasmic presence in several human tissues, including the cerebellum[9]. The protein is primarily predicted from sequence and in silico analysis rather than extensive functional studies, and there are currently no drugs, targeted therapies, or biomarker applications associated with NHSL2[1][3][5][11]. No evidence supports its direct involvement in major disease processes outside rare genetic associations (e.g., Nance-Horan syndrome)[1]. The alternative alias "TPT1-like protein" refers to sequence similarity, but NHSL2 should not be confused with TPT1 (Translationally Controlled Tumor Protein), which has more substantial roles in apoptosis, cancer, and immune regulation[2][6][8][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NHS-like protein 2 (NHSL2).